Overzicht Proefschriften

Tips in using the search/filter fields

Select on a part of the content: ede	Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes)	Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010	Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011	Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.

Displaying 101-150 of 278 results.

Titel	Promovendus	Promotor 1	Promotor 2	Copromotor 1	Copromotor 2	Universiteit	Promotiejaar	Trefwoorden

Medication Optimization; exploring the use of a clinical decision support system	Wit H.A.J.M. de, PhD	Schols J.M.G.A., prof. dr.		Kuy P.H.M. van der, dr.	Janknegt R., PharmD PhD	Universiteit Maastricht (UM)	2016	Clinical pharmacology; Clinical rules; CDSS
Medication surveillance in older patients : clinical decision support as the next step in medication safety	Hurkens K.P.M.G., MD PhD MBA	Stehouwer C.D.A., prof. dr.		Kuy P.H.M. van der, dr.	Janknegt R., PharmD PhD	Universiteit Maastricht (UM)	2013	Clinical pharmacology; Elderly; clinical rules
Clinical pharmacology of nevirapine in HIV-infected patients in Tanzania	Muro E.P., PhD	Burger D.M., prof. dr.	Dolmans W.M.V., prof. dr.			Radboud Universiteit (RU)	2014	Clinical pharmacology; HIV; Pharmacokinetics; therapy drug monitoring
Clinical pharmacological aspects of mitochondrial function in muscle	Diemen M.P.J. van, PhD	Cohen A.F., prof. dr.	Nelissen R.G.H.H., prof. dr.	Groeneveld G.J., prof. dr.		Universiteit Leiden (UL)	2021	Clinical pharmacology; Huntington's disease; Mitochondrial function; Magnetic Resonance Spectroscopy; Sarcopenia; Phosphocreatine recovery rate; Knee; Total knee arthroplasty; Wearables; Peripheral blood mononuclear cells; Protoporphorin IX Triple State Lifetime techn;
Treatment adherence in hypertension : methodological aspects and new strategies	Onzenoort H.A.W. van, PhD	Leeuw P.W. de, prof. dr.	Neef C., prof. dr.	Kuy P.H.M. van der, dr.		Universiteit Maastricht (UM)	2012	Clinical pharmacology; hypertension; compliance
HIV treatment: a clinical pharmacology perspective	Luin M. van, dr.	Hekster Y.A., prof. dr.		Burger D.M., prof. dr.	Richter C., dr.	Radboud Universiteit (RU)	2010	Clinical pharmacology; Pharmacokinetics; HIV; Therapeutic drug monitoring; drug-drug interactions; antiretroviral drugs
Clinical pharmacological studies in tuberculosis patients	Semvua H.H., PhD	Burger D.M., prof. dr.		Aarnoutse R.E., dr.	Boeree M.J., dr.	Radboud Universiteit (RU)	2014	Clinical pharmacology; Pharmacokinetics; Tuberculosis
Rational prescribing in Europe: are future doctors well prepared?	Brinkman D.J., PhD	Agtmael M.A. van, prof. dr.		Richir M.C., MD PhD	Tichelaar J., dr.	Vrije Universiteit Amsterdam (VU)	2018	Clinical pharmacology; Pharmacotherapy; Prescribing;
Optimizing clinical trial design in chronic kidney disease.	Waijer S.W.	Lambers Heerspink H.J., prof. dr.	Gansevoort R.T., prof. dr.			Rijksuniversiteit Groningen (RUG)	2022	Clinical Trial design, Chronic Kidney Diseae
Trials & tribulations : studies on the fate, transparency and efficiency of clinical drug trials	Bogert C.A. van den, PhD	Leufkens H.G.M., prof. dr.		Souverein P.C., dr.	Janssen S.W.J., dr.	Universiteit Utrecht (UU)	2017	Clinical trials; Drug development; Publication bias; Regulatory science;
ColoPulse tablets in inflammatory bowel disease: formulation, potential application and evaluation	Maurer J.M., PhD	Kosterink J.G.W., prof. dr.	Frijlink H.W., prof. dr.	Woerdenbag H.J., dr.		Rijksuniversiteit Groningen (RUG)	2017	ColoPulse tablets; Inflammatory bowel disease;
End-organ damage in diabetes: exploring innovative targets and therapies	Hamidi M., PhD	Henning R.H., prof. dr.		Buikema J.H., dr.	Deelman L.E., dr.	Rijksuniversiteit Groningen (RUG)	2015	Diabetes mellitus;
Predicting and improving individual long-term outcome in patients with diabetes and nephropathy; dterminants of response to RAAS inhibition	Holtkamp F.A., PhD	Graeff P.A. de, prof. dr.	Zeeuw D. de, prof. dr.	Lambers Heerspink H.J., prof. dr.		Rijksuniversiteit Groningen (RUG)	2011	diabetes; nephropathy; predicting and improving long term outcome
Better prediction of drug response in diabetic kidney disease	Idzerda N.M.A.	Lambers Heerspink H.J., prof. dr.	Zeeuw D. de, prof. dr.	Pena M.J., PhD		Rijksuniversiteit Groningen (RUG)	2020	Diabetic kidney disease; Drug response;
The role of differentiation factor 15 in diabetic kidney injury	Mazagová M., PhD	Henning R.H., prof. dr.		Deelman L.E., dr.		Rijksuniversiteit Groningen (RUG)	2012	Diabetic kidney disease; Growth differentiation factor 15;
Neuropharmacology of novel dopamine modulators	Beek E.T te, PhD	Gerven J.M.A. van, prof. dr.	Cohen A.F., prof. dr.			Universiteit Leiden (UL)	2014	Dopamine Antagonist Drug development Pharmacokinetics Pharmacodynamics Schizophrenia Drug addiction Tachykinins
Implementing dried blood spot sampling in transplant patient care	Touw D.J., prof. dr.	Touw D.J., prof. dr.	Bakker S.J.L., prof. dr.			Rijksuniversiteit Groningen (RUG)	2020	dried blood spot sampling, transplant patient care
Implementing dried spot sampling in transplant patient care	Veenhof H.	Touw D.J., prof. dr.	Bakker S.J.L., prof. dr.	Berger S.P., prof. dr.		Rijksuniversiteit Groningen (RUG)	2020	dried blood spot; Transplantation;
Drug development and new targets for redox disturbances in experimental vascular disease	Henning R.H., prof. dr.			Deelman L.E., dr.	Buikema J.H., dr.	Rijksuniversiteit Groningen (RUG)	2022	Drug development, redox disturbance, experimental vascular disease
The influence of morbid obesity on the pharmacokinetics and pharmacodynamics of drugs in adolescents and adults : focus on propofol and nadroparin	Diepstraten J., PhD	Knibbe C.A.J., prof. dr.	Vinks A.A., prof. dr.	Dongen H.P.A. van, dr.	Ramshorst B. van, dr.	Universiteit Leiden (UL)	2013	Drug dosing; Low-molecular-weight heparines; Nadroparin; Obesity; Pharmacodynamics; Pharmacokinetics; Propofol;
Therapeutic drug monitoring: how to improve moxifloxacin exposure in tuberculosis patients	Pranger A.	Kosterink J.G.W., prof. dr.	Werf T.S. van der, prof. dr.	Uges D.R.A., prof. dr.		Rijksuniversiteit Groningen (RUG)	2018	drug monitoring moxifloxacin exposure tuberculosis
Therapeutic drug monitoring in tuberculosis treatment	Elsen S.H.J. van den	Alffenaar J.W.C., prof. dr.	Werf T.S. van der, prof. dr.			Rijksuniversiteit Groningen (RUG)	2020	drug monitoring, tuberculosis treatment
Clinical pharmacology and therapeutic drug monitoring of voriconazole	Veringa A., PhD	Alffenaar J.W.C., prof. dr.	Kosterink J.G.W., prof. dr.	Werf T.S. van der, prof. dr.		Rijksuniversiteit Groningen (RUG)	2019	drug monitoring; voriconazole
Information for rational drug prescribing to older patients : availability and applicability	Beers E., PhD	Egberts A.C.G., prof. dr.	Leufkens H.G.M., prof. dr.	Jansen P.A.F., dr.		Universiteit Utrecht (UU)	2014	Drug prescribing; Older patients; Geriatrics; Medicines; Drug safety; Information; Aged;
Regulatory benefit-risk assessment : different perspectives	Arnardottir A.H., PhD	Haaijer-Ruskamp F.M., prof. dr.	Graeff P.A. de, prof. dr.	Mol P.G.M., dr.	Straus S.M.J.M., dr.	Rijksuniversiteit Groningen (RUG)	2013	drug registration benefit risk
Patient compliance with drug storage recommendations	Vlieland N.D., PhD	Egberts A.C.G., prof. dr.	Bouvy M.L., prof. dr.	Gardarsdottir H., dr.	Bemt B.J.F. van den, dr.	Universiteit Utrecht (UU)	2018	Drug storage; Temperature conditions; Biologic drugs; Biologicals; Tumor necrosis factor-alpha inhibitors; Oral anticancer drugs; Immunogenicity; Pharmaceutical supply chain; Quality; Personality traits; Aggregation;
Optimizing treatment with psychotropic agents through precision drug therapy: It is not about the mean	Berm E.J.J., PhD	Wilffert B, prof. dr.	Hak E., prof. dr.	Maring J.G., dr.		Rijksuniversiteit Groningen (RUG)	2016	Drug therapy; Psychotropic agents; Treatment individualization; Precision medicine;
Monitoring drug therapy in hospitalized patients	Uijtendaal E.V., PhD	Egberts A.C.G., prof. dr.	Solinge W.W. van, prof. dr.	Zwart-van Rijkom J.E.F., dr.		Universiteit Utrecht (UU)	2014	Drug-drug interactions; Intensive care; Laboratory monitoring; Serum potassium; Patient safety; Medication errors; Adverse drug reactions; Clinical decision support;
Drug-related problems: risk factors and the role of clinical pharmacists	Zaal R.J., PhD	Vulto A.G., prof. dr.	Haaijer-Ruskamp F.M., prof. dr.	Bemt P.M.L.A. van den, dr.		Erasmus Universiteit Rotterdam (EUR)	2016	Drug-related problems; Risk factors;
Medication optimisation : methodological aspects and new strategies	Mestres Gonzalvo C., PhD	Verhey F.R., prof.dr.	Kuy P.H.M. van der, dr.	Janknegt R., PharmD PhD		Universiteit Maastricht (UM)	2018	Elderly; Geriatrics; Hospital pharmacists; Medication use; Model-based; Model validation; Older patients; Optimal pharmacotherapy; Pharmaceutical care; Pharmacotherapy; Pharmacovigilance;
Multi dose drug dispensing for older patients in primary care	Mertens B.J., PhD	Bouvy M.L., prof. dr.	Marum R.J. van, prof. dr.	Kwint H.F., dr.		Universiteit Utrecht (UU)	2019	Elderly; Primary care; Multi-dose drug dispensing;
The quantification of growth hormone secretion : application of model-informed drug development in acromegaly	Esdonk M.J van	Graaf P.H., Prof.dr.	Burggraaf J., prof. dr.	Stevens J., Dr.		Universiteit Leiden (UL)	2019	Endocrinology Pulsatile profiles Population modelling Pharmacokinetic Pharmacodynamic modelling Clinical trial simulation
Predictive value of treatment quality indicators on outcomes in patients with diabetes	Sidorenkov G., PhD	Haaijer-Ruskamp F.M., prof. dr.	Zeeuw D. de, prof. dr.	Denig P., prof. dr.	Voorham J., dr.	Rijksuniversiteit Groningen (RUG)	2013	Endocrinology; Hemoglobine; Glycoproteins; Diabetes mellitus; Risk management;
Sex hormones and cardiometabolic risk	Glisic M., PhD	Danser A.H.J., prof. dr.	Franco Duran O.H., Prof.dr.	Roks A.J.M., dr.		Erasmus Universiteit Rotterdam (EUR)	2018	Epidemiology; Pharmacology; Risk factors; Sex hormonesCardiovascular disease; Metabolism;
Determinants of treatment outcomes in epilepsy	Wassenaar M., PhD	Egberts A.C.G., prof. dr.		Leijten F.S.S., dr.	Uijl S.G., dr.	Universiteit Utrecht (UU)	2014	Epilepsy; Treatment; Treatment outcomes; Quality of life; Patient-perspectives; Clinical determinants; Seizures; Pharmacology; Daily practice; Community-based;
Towards better fall prevention - examining the interplay between factors that influence gait in older patients	Groot M.H. de, PhD	Beijnen J.H., prof. dr.		Lamoth C.J.C., dr.		Universiteit Utrecht (UU)	2017	Falls; Gait analysis; Accelerometry; Frailty; Osteoporosis; Maturation; Medication use; Medication use; Geriatrics; Older patients;
Fluorescence-enhanced surgical navigation : towards tailored tumor detection	Boogerd L.S.F., PhD	Velde C.J.H. Van de, Prof.dr.	Burggraaf J., prof. dr.	Vahrmeijer A.L., Dr.		Universiteit Leiden (UL)	2019	Fluorescence guided surgery tailored tumor detection Intraoperative tumor imaging ICG CEA targeted tumor detection
Methods for improving the safety of fluoropyrimidine anticancer drugs	Jacobs B.A.W., PhD	Schellens J.H.M., prof. dr.	Beijnen J.H., prof. dr.	Nuijen B., dr.		Universiteit Utrecht (UU)	2016	Fluoropyrimidines; Capecitabine; 5-fluorouracil; Dihydropyrimidine dehydrogenase; Thymidylate synthase; Safety; Phenotyping; Circadian rhythm;
Patients at increased fracture risk : identification and pharmacological treatment	Klop C., PhD	Leufkens H.G.M., prof. dr.	Bijlsma J.W.J., prof. dr.	Vries F. de, prof. dr.	Welsing P.M.J., dr.	Universiteit Utrecht (UU)	2016	Fragility fracture; Hip fracture; Hip; Osteoporosis; Biphosphonate; Absolute risk prediction; FRAX;
Pharmacogenetics of sunitinib in metastatic renal cell carcinoma	Diekstra M.H.M., dr	Guchelaar H.J., prof. dr.		Swen J.J., PhD		Universiteit Leiden (UL)	2017	Genetics; Pharmacogenetics; Renal function;
Mounting an attack on the glioblastoma triad : proliferation, invasion and resistance	Gooijer M.C. de, PhD	Beijnen J.H., prof. dr.		Tellingen O. van, dr.		Universiteit Utrecht (UU)	2019	Glioblastoma; Blood-brain barrier; Therapy development; Pharmacology; Cell biology; Combination therapy; Mouse models;
Exploring the role of glucagon in glucose homeostasis	Dongen M.G.J. van, PhD	Cohen A.F., prof. dr.	Romijn J.A., prof dr	Burggraaf J., prof. dr.		Universiteit Leiden (UL)	2015	Glucagon; Diabetes mellitus; Glucose homeostasis; Glucagon challenge; Glucagon receptor antagonist; Insulin
Clinical risk management of drug-related hospital admissions: strategies for their identification, reduction and monitoring	Warlé-van Herwaarden M., PhD	Smet P.A.G.M. de, prof. dr.	Sturkenboom M.C.J.M., prof. dr.	Kramers C., dr.	Herings R.M.C., dr.	Radboud Universiteit (RU)	2015	Guideline adherence; medication safety; laboratory monitoring
Introducing Clinical Pharmacology to Hepatitis C Therapy	Kanter C.T.M.M. de, PhD	Burger D.M., prof. dr.	Drenth J.P.H., prof. dr.	Dofferhoff A.S.M., dr.		Radboud Universiteit (RU)	2015	Hepatitis C; Clinical Pharmacology; Therapeutic drug monitoring; drug drug interactions
Hibernating mitochondria, the cool key to cellular protection and transplant optimization; Mitochondrial aspects of hibernators and non-hibernators in hypothermia	Hendriks K.D.W.	Henning R.H., prof. dr.	Leuverink H.G.D., prof. dr.			Rijksuniversiteit Groningen (RUG)	2021	Hibernating mitochondria
Immunological aspects of hibernation as leads in the prevention of acute organ injury.	Bouma H.R., PhD	Henning R.H., prof. dr.	Kroese F.G.M., prof. dr.	Strijkstra A.M., dr.		Rijksuniversiteit Groningen (RUG)	2013	hibernation acute organ injury immunological
Modulation of endogenous H2S productin: its role in hibernation and pharmacological cell protection	Talaei F., PhD	Henning R.H., prof. dr.	Schmidt M., prof. dr.			Rijksuniversiteit Groningen (RUG)	2012	Hibernation; Endogenous H2S production; Pharmacological cell protection; Hypothermia; Cysteinyldopa;
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too little	Colbers E.P.H., PhD	Burger D.M., prof. dr.				Radboud Universiteit (RU)	2015	HIV; antiretroviral agents; clinical pharmacology; drug drug interactions
Optmizing long-term care for hiv-infected patients in Thailand	Ramautarsing R.A., PhD	Burger D.M., prof. dr.		Wit F.W.N.M., dr.	Wijgert J.H.H.M. van de, dr.	Universiteit van Amsterdam (UvA)	2013	HIV; clinical pharmacology
Early phase clinical drug development for HPV-induced disorders: novel tools and treatments	Rijsbergen M.	Burggraaf J., prof. dr.		Rissmann R, prof.dr.	Poelgeest M.I.E. van, dr.	Universiteit Leiden (UL)	2020	HPV-induced diseases;